Keisuke Kirita
Kashiwa, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Final Analysis Data and Exploratory Biomarker Analysis of a Randomized Phase 2 Study of Osimertinib Plus Bevacizumab Versus Osimertinib Monotherapy for Untreated Patients With Nonsquamous NSCLC Harboring EGFR Mutations: The WJOG9717L Study.
Journal: JTO clinical and research reports
Published: May 13, 2024
Clinical Significance of a Prospective Large Genomic Screening for SCLC: The Genetic Classification and a Biomarker-Driven Phase 2 Trial of Gedatolisib.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: October 16, 2023
Randomized Phase 2 Study of Osimertinib Plus Bevacizumab Versus Osimertinib for Untreated Patients With Nonsquamous NSCLC Harboring EGFR Mutations: WJOG9717L Study.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: February 26, 2022
A case of pulmonary foreign body granuloma formation after transcatheter arterial chemoembolization for hepatocellular carcinoma.
Journal: Respirology case reports
Published: September 14, 2021
Omission of Throat Anesthesia Using Jackson's Spray Prior to Bronchoscopy for Preventing Aerosol Generation: A Survey Through Patient Distress Questionnaire.
Journal: Cureus
Published: August 16, 2021
Correction to: Validity of using immunohistochemistry to predict treatment outcome in patients with non-small cell lung cancer not otherwise specified.
Journal: Journal of cancer research and clinical oncology
Published: July 23, 2021
Comparison of the efficiency of endobronchial ultrasound-guided transbronchial needle aspiration using a 22G needle versus 25G needle for the diagnosis of lymph node metastasis in patients with lung cancer: a prospective randomized, crossover study.
Journal: Translational lung cancer research
Published: June 09, 2021
The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung cancer.
Journal: Nature
Published: May 27, 2021
A Phase II Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis From NSCLC: Results for the T790M Cohort of the OCEAN Study (LOGIK1603/WJOG9116L).
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: April 02, 2021
Impact of concomitant medication on clinical outcomes in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors: A retrospective study.
Journal: Thoracic cancer
Published: March 28, 2021
High proportion of tumor necrosis predicts poor survival in surgically resected high-grade neuroendocrine carcinoma of the lung.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 20, 2021
Last Updated: 09/26/2026